Noliprel Forte (Perindopril Tert-Butylamine, Indapamide)

Perindopril tert‑butylamine, the active ingredient in Noliprel Forte, is an ACE inhibitor presented as an oral tablet for oral use. Combined with indapamide, it is employed to lower elevated blood pressure in adult patients with hypertension. It is indicated for patients who require combined renin‑angiotensin system blockade and diuretic therapy to achieve target blood pressure levels.

GNH USA supplies Noliprel Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice, ensuring product integrity through controlled temperature, moisture protection, and secure packaging during global shipment to healthcare providers.

Noliprel Forte, a combination ACE inhibitor and thiazide‑like diuretic, is used to manage hypertension.

- Hypertension: lowers elevated systolic and diastolic blood pressure in adults. - Essential hypertension requiring combined ACE inhibition and diuretic therapy: helps achieve target blood pressure when monotherapy is insufficient.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness, especially after standing. - Headache: mild to moderate intensity. - Fatigue or general weakness. - Increased urinary frequency due to diuretic effect. - Electrolyte disturbances such as low potassium.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Severe hypotension: marked drop in blood pressure causing fainting. - Acute renal impairment or worsening of existing kidney disease. - Hyperkalemia: elevated blood potassium levels. - Blood dyscrasias: rare blood cell abnormalities. - Pancreatitis: inflammation of the pancreas presenting with abdominal pain.

Before initiating therapy, clinicians should assess patient history and monitor relevant parameters. - Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Renal function: check serum creatinine and eGFR periodically. - Electrolyte levels: especially potassium and sodium, due to diuretic component. - Pregnancy: contraindicated in pregnancy (Category D) because of fetal risk. - Elderly patients: start at lower dose and monitor for orthostatic hypotension. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Noliprel Forte may interact with several medicines; careful review is required.

Major Interactions (Avoid): - Aliskiren (in pregnancy): combined renin‑angiotensin blockade can cause fetal toxicity. - Potassium‑sparing diuretics or supplements: risk of dangerous hyperkalemia. - Other ACE inhibitors or ARBs: additive blood pressure lowering and renal effects. - Lithium: increased lithium levels leading to toxicity. - NSAIDs (e.g., ibuprofen): may blunt antihypertensive effect and impair renal function.

Moderate Interactions (Monitor Closely): - Thiazide‑like diuretics with other antihypertensives: may cause excessive hypotension. - Corticosteroids: can exacerbate potassium loss. - Antidiabetic agents: diuretic may affect glucose control. - Anticoagulants: potential for increased bleeding risk. - Antimicrobials such as trimethoprim: may raise potassium levels.